Scientific Online Resource System

International Bulletin of Otorhinolaryngology

The role of MRI in staging and radiotherapy treatment planning in locally advanced nasopharyngeal carcinoma – case report

Hr. Ivanovska, E. Encheva, G. Iliev, R. Georgiev, B. Chaushev, P. Bochev, Ts. Yordanova, E. Dimitrova, N. Tsonev, I. Shterev

Abstract

Nasopharyngeal carcinoma (NPC) is a rare disease. The “Golden imaging standard” for primary tumor and regional lymph nodes staging in NPC is MRI- magnetic resonance imaging. Radiotherapy is the main treatment modality in both early and locoregional advanced NPC. Radiotherapy alone is recommended only in T1N0M0 stage NPC, while in higher stages for best treatment results contributes radiotherapy with concomitant chemotherapy. The aim is to report a case of a patients with NPC presented to our department with clinical and MRI data for scull base and brain invasion. Tumor staging included PET/CT scan and MRI, which were used also for treatment
planning. The patient was treated with definitive radiotherapy to 64 Gy, concomitantly with weekly Cisplatin. VMAT and IGRT treatment techniques were used. One year later a complete response is observed without late toxicity and grade 2 dry mouth. Using of MRI for initial staging and radiotherapy planning in NPC is very important due to precise findings of the tumor invasion and a correct definition of the treatment volume. MRI staging should be part of the initial staging and follow up algorithm in all patients with NPC.

Keywords

Nasopharyngeal cancer, radiotherapy, MRI, staging, target volumes contouring, PET-CT

Full Text


References

Young L. S., and Dawson C. W. 2014.Epstein Barr virus and nasopharyngeal carcinoma. Chin. J. Cancer 33:581–590.

Raab Traub N. 2002. Epstein Barr virusin pathogenesis of NPC. Semin. Cancer Biol. 12:431–441.

Bulgaria National Cancer Registry 2016

Brennan, Bernadette (June 26, 2006). “Nasopharyngeal carcinoma”. Orphanet Journal of Rare Diseases. 1:23: 1–5.

Lozano, R (Dec 15, 2012). “Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010”. Lancet. 380 (9859): 2095–128.

Desislava Skerleva and Stefan Stoyanov. Nasopharyngeal carcinoma-causes for delay of diagnosis. Deutsche Gesellschaft für Hals-Nasen Ohren-Heilkunde, Kopf- und Hals-Chirurgie. 84. Jahres versammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopfund Hals-Chirurgie. Nürnberg, 08. 12.05.2013. Düsseldorf: GermanMedical Science GMS Publishing House; 2013. Doc13hnod207

Survival Rates for Nasopharyngeal Cancer by Stage, NCS, 20.12.2017

King AD, Vlantis AC, Bhatia KS, etal. Primary nasopharyngeal carcinoma: diagnostic accuracy of MR imaging versus that of endoscopy and endoscopic biopsy. Radiology 2011; 258:531–537

Lau J. S., Yeo W., Chan Y. L. et al. 2004. Intracranial metastasis from nasopharyngeal carcinoma: report of three cases and review of literature. J. Clin. Oncol. 22, no. 14_suppl:5608.

Zhang S. X., Han P. H., Zhang G. Q. , et al. 2014. Comparison ofSPECT/CT, MRI and CT in diagnosis of skull base bone invasion in nasopharyngeal carcinoma. Biomed. Mater. Eng. 24:1117–1124.

Zhu A., Lee D., and Shim H. 2011. Metabolic PET imaging in cancer detection and therapy response. Semin. Oncol. 38:55–69.

Mohandas A., Marcus C., Kang H. et al. 2014. FDG PET/CT in the management of nasopharyngeal carcinoma. AJR Am. J. Roentgenol. 203:W146–W157.

„Initiative for Vaccine Research (IVR): Viral cancers“. World Health Organization. Retrieved 2 October 2012.

Dirix P, Haustermans K, Vandecaveye V. The value of magnetic resonance imaging for radiotherapy planning. Seminars in radiation oncology. 2014;24(3):151-9.

Lai V, Khong PL. Updates on MR imaging and F-FDG PET/CT imaging in nasopharyngeal carcinoma. Oral Oncol 2013;50:539–48.




DOI: http://dx.doi.org/10.14748/orl.v14i2.6769

Refbacks

Font Size


|